BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 24649241)

  • 1. Jumonji/Arid1b (Jarid1b) protein modulates human esophageal cancer cell growth.
    Kano Y; Konno M; Ohta K; Haraguchi N; Nishikawa S; Kagawa Y; Hamabe A; Hasegawa S; Ogawa H; Fukusumi T; Noguchi Y; Ozaki M; Kudo T; Sakai D; Satoh T; Ishii M; Mizohata E; Inoue T; Mori M; Doki Y; Ishii H
    Mol Clin Oncol; 2013 Jul; 1(4):753-757. PubMed ID: 24649241
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depletion of JARID1B induces cellular senescence in human colorectal cancer.
    Ohta K; Haraguchi N; Kano Y; Kagawa Y; Konno M; Nishikawa S; Hamabe A; Hasegawa S; Ogawa H; Fukusumi T; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Noguchi Y; Ozaki M; Kudo T; Sakai D; Satoh T; Fukami M; Ishii M; Yamamoto H; Doki Y; Mori M; Ishii H
    Int J Oncol; 2013 Apr; 42(4):1212-8. PubMed ID: 23354547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A temporarily distinct subpopulation of slow-cycling melanoma cells is required for continuous tumor growth.
    Roesch A; Fukunaga-Kalabis M; Schmidt EC; Zabierowski SE; Brafford PA; Vultur A; Basu D; Gimotty P; Vogt T; Herlyn M
    Cell; 2010 May; 141(4):583-94. PubMed ID: 20478252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic significance of RBP2-H1 variant of JARID1B in melanoma.
    Kuźbicki Ł; Lange D; Stanek-Widera A; Chwirot BW
    BMC Cancer; 2017 Dec; 17(1):854. PubMed ID: 29246117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RBP2-H1/JARID1B is a transcriptional regulator with a tumor suppressive potential in melanoma cells.
    Roesch A; Mueller AM; Stempfl T; Moehle C; Landthaler M; Vogt T
    Int J Cancer; 2008 Mar; 122(5):1047-57. PubMed ID: 17973255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. PLU-1/JARID1B overexpression predicts proliferation properties in head and neck squamous cell carcinoma.
    Cui Z; Song L; Hou Z; Han Y; Hu Y; Wu Y; Chen W; Mao L
    Oncol Rep; 2015 May; 33(5):2454-60. PubMed ID: 25777981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone demethylase JARID1B/KDM5B promotes aggressiveness of non-small cell lung cancer and serves as a good prognostic predictor.
    Kuo KT; Huang WC; Bamodu OA; Lee WH; Wang CH; Hsiao M; Wang LS; Yeh CT
    Clin Epigenetics; 2018 Aug; 10(1):107. PubMed ID: 30092824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional Regulation of JARID1B/KDM5B Histone Demethylase by Ikaros, Histone Deacetylase 1 (HDAC1), and Casein Kinase 2 (CK2) in B-cell Acute Lymphoblastic Leukemia.
    Wang H; Song C; Ding Y; Pan X; Ge Z; Tan BH; Gowda C; Sachdev M; Muthusami S; Ouyang H; Lai L; Francis OL; Morris CL; Abdel-Azim H; Dorsam G; Xiang M; Payne KJ; Dovat S
    J Biol Chem; 2016 Feb; 291(8):4004-18. PubMed ID: 26655717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histone demethylase jumonji AT-rich interactive domain 1B (JARID1B) controls mammary gland development by regulating key developmental and lineage specification genes.
    Zou MR; Cao J; Liu Z; Huh SJ; Polyak K; Yan Q
    J Biol Chem; 2014 Jun; 289(25):17620-33. PubMed ID: 24802759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Jumonji/ARID1 B (JARID1B) protein promotes breast tumor cell cycle progression through epigenetic repression of microRNA let-7e.
    Mitra D; Das PM; Huynh FC; Jones FE
    J Biol Chem; 2011 Nov; 286(47):40531-5. PubMed ID: 21969366
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of the transcription repressor PLU-1/JARID1B.
    Scibetta AG; Santangelo S; Coleman J; Hall D; Chaplin T; Copier J; Catchpole S; Burchell J; Taylor-Papadimitriou J
    Mol Cell Biol; 2007 Oct; 27(20):7220-35. PubMed ID: 17709396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunohistochemical detection and clinicopathological significance of JARID1B/KDM5B and P16 expression in invasive ductal carcinoma of the breast.
    Zhao LH; Liu HG
    Genet Mol Res; 2015 May; 14(2):5417-26. PubMed ID: 26125737
    [TBL] [Abstract][Full Text] [Related]  

  • 13. JARID1B modulates lung cancer cell proliferation and invasion by regulating p53 expression.
    Shen X; Zhuang Z; Zhang Y; Chen Z; Shen L; Pu W; Chen L; Xu Z
    Tumour Biol; 2015 Sep; 36(9):7133-42. PubMed ID: 25877751
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PLU-1/JARID1B/KDM5B is required for embryonic survival and contributes to cell proliferation in the mammary gland and in ER+ breast cancer cells.
    Catchpole S; Spencer-Dene B; Hall D; Santangelo S; Rosewell I; Guenatri M; Beatson R; Scibetta AG; Burchell JM; Taylor-Papadimitriou J
    Int J Oncol; 2011 May; 38(5):1267-77. PubMed ID: 21369698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histone demethylase Jarid1b is required for hematopoietic stem cell self-renewal in mice.
    Stewart MH; Albert M; Sroczynska P; Cruickshank VA; Guo Y; Rossi DJ; Helin K; Enver T
    Blood; 2015 Mar; 125(13):2075-8. PubMed ID: 25655602
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting JARID1B's demethylase activity blocks a subset of its functions in oral cancer.
    Facompre ND; Harmeyer KM; Sahu V; Gimotty PA; Rustgi AK; Nakagawa H; Basu D
    Oncotarget; 2018 Feb; 9(10):8985-8998. PubMed ID: 29507668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of small molecule inhibitors of Jumonji AT-rich interactive domain 1B (JARID1B) histone demethylase by a sensitive high throughput screen.
    Sayegh J; Cao J; Zou MR; Morales A; Blair LP; Norcia M; Hoyer D; Tackett AJ; Merkel JS; Yan Q
    J Biol Chem; 2013 Mar; 288(13):9408-17. PubMed ID: 23408432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing JARID1B suppresses oncogenicity, stemness and increases radiation sensitivity in human oral carcinoma.
    Lin CS; Lin YC; Adebayo BO; Wu A; Chen JH; Peng YJ; Cheng MF; Lee WH; Hsiao M; Chao TY; Yeh CT
    Cancer Lett; 2015 Nov; 368(1):36-45. PubMed ID: 26184998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic Regulation of Angiogenesis by JARID1B-Induced Repression of HOXA5.
    Fork C; Gu L; Hitzel J; Josipovic I; Hu J; SzeKa Wong M; Ponomareva Y; Albert M; Schmitz SU; Uchida S; Fleming I; Helin K; Steinhilber D; Leisegang MS; Brandes RP
    Arterioscler Thromb Vasc Biol; 2015 Jul; 35(7):1645-52. PubMed ID: 26023081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histone demethylase lysine demethylase 5B in development and cancer.
    Han M; Xu W; Cheng P; Jin H; Wang X
    Oncotarget; 2017 Jan; 8(5):8980-8991. PubMed ID: 27974677
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.